Cognoa is a groundbreaking brand that specializes in early childhood development and pediatric behavioral health. They are dedicated to making life-changing early diagnosis and interventions possible, ultimately improving the lives of children and families. By utilizing breakthrough innovations and responsible AI, Cognoa offers a range of products and services that optimize resources and save valuable time.

Their flagship product, Canvas Dx, is the first and only FDA authorized diagnostic solution designed to diagnose or rule out autism in children aged 1. 5 to 6 years within days, rather than months or years. This remote and digital evaluation of children with developmental concerns ensures faster access to the next steps of care for all children, regardless of their needs.

Cognoa recognizes that early interventions have the greatest impact on child developmental health. Unfortunately, most children with developmental conditions aren't diagnosed until after the age of 4, and many underserved children are missed altogether. By prioritizing early diagnosis and providing data-driven approaches, Cognoa aims to overcome prevailing biases and eliminate costly delays in the healthcare system.

With their whole-child approach and innovative technology, Cognoa empowers both healthcare professionals and families, giving them the tools and knowledge to realize their most fulfilling lives. Join Cognoa in their mission to revolutionize child developmental health and ensure an equitable path to care for every child